+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Apellis Pharmaceuticals - logo

Apellis Pharmaceutical was founded in 2009 in Crestwood, U.S.A. It is a company with the aim of innovating and creating products to treat autoimmune and inflammatory diseases. Our lead compounds are designed to broadly inhibit complement C3, which is the central protein in the complement system.The complement system plays a key role in a wide range of autoimmune and inflammatory diseases. They believe with the use of C3 inhibition it may correct the immunological dysfunction. The approach they apply to this process is known as complement immunotherapy.

Warm Autoimmune Hemolytic Anemia (WAIHA) - Pipeline Insight, 2020 - Product Thumbnail Image

Warm Autoimmune Hemolytic Anemia (WAIHA) - Pipeline Insight, 2020

  • Drug Pipelines
  • September 2020
  • 70 pages
From
From
From
From
From
From
From
Cold Agglutinin Disease (CAD)- - Pipeline Insight, 2020 - Product Thumbnail Image

Cold Agglutinin Disease (CAD)- - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
From
From
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 140 pages
From
From
Prefilled Syringes Market (5th Edition), 2020-2030 - Product Thumbnail Image

Prefilled Syringes Market (5th Edition), 2020-2030

  • Report
  • January 2020
  • 554 Pages
From
From
Loading Indicator
adroll